These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 132372)

  • 1. Use of an IgG fragment prepared with particulate plasmin to study the C1 binding and activation.
    Arlaud GJ; Meyer CM; Colomb MG
    FEBS Lett; 1976 Jul; 66(1):132-6. PubMed ID: 132372
    [No Abstract]   [Full Text] [Related]  

  • 2. The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex.
    Goers JW; Ziccardi RJ; Schumaker VN; Glovsky MM
    J Immunol; 1977 Jun; 118(6):2182-91. PubMed ID: 559020
    [No Abstract]   [Full Text] [Related]  

  • 3. Functionally active C1 on the surface of human peripheral lymphocytes: its role in the complement-mediated inhibition of the Fc receptor of B lymphocytes.
    Füst G; Erdei A; Sármay G; Medgyesi GA; Gergely J
    Clin Immunol Immunopathol; 1976 May; 5(3):377-87. PubMed ID: 776475
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitation of immune complexes by competitive inhibition of binding of Clq to insoluble IgG aggregates.
    Fletcher DS; Lin TY
    J Immunol Methods; 1977; 15(1):39-45. PubMed ID: 845441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1 fixation and classical complement pathway activation by a fragment of the Cmu4 domain of IgM.
    Hurst MM; Volanakis JE; Stroud RM; Bennett JC
    J Exp Med; 1975 Nov; 142(5):1322-6. PubMed ID: 1194853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative binding of a complement component to antigen-antibody complexes. III. Complexes containing IgM antibodies.
    Kuo CY; Thompson JJ; Hoffmann LG
    Z Immunitatsforsch Immunobiol; 1976 Sep; 152(2):151-66. PubMed ID: 960974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a plasmin-digest fragment of rabbit immunoglobulin gamma that binds antigen and complement.
    Colomb M; Porter RR
    Biochem J; 1975 Feb; 145(2):177-83. PubMed ID: 239679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: C1-esterase inactivators and C4 in malignant diseases.
    Bach-Martensen N; Osther K; Stroyer I
    Lancet; 1975 Sep; 2(7933):499-500. PubMed ID: 51308
    [No Abstract]   [Full Text] [Related]  

  • 9. The Clq receptor site on immunoglobulin G.
    Burton DR; Boyd J; Brampton AD; Easterbrook-Smith SB; Emanuel EJ; Novotny J; Rademacher TW; van Schravendijk MR; Sternberg MJ; Dwek RA
    Nature; 1980 Nov; 288(5789):338-44. PubMed ID: 6776418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A solid-phase radioimmunoassay for C1q-binding immune complexes. I. Delta IgG as indicator molecule.
    Svehag SE
    Scand J Immunol; 1975; 4(7):687-97. PubMed ID: 1198070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the interaction between the complement component Clq and immune complexes.
    Allan R; Rodrick M; Knobel HR; Isliker H
    Int Arch Allergy Appl Immunol; 1979; 58(2):140-8. PubMed ID: 33905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
    Betz SJ; Page N; Estrade C; Isliker H
    J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrolysis of a synthetic amide substrate by human C1 esterase (C1s).
    Morgan PH; Nair IG
    J Immunol; 1977 Jul; 119(1):19-25. PubMed ID: 17638
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of C1s and C4. A binding phenomenon.
    Taubman SB
    Biochim Biophys Acta; 1975 Jun; 393(2):542-55. PubMed ID: 125105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EAC4 and EAC14 production without purified Ci.
    Linscott WD
    J Immunol; 1975 Dec; 115(6):1625-30. PubMed ID: 241767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inactivator of the first component of human complement (C1INA): the complex formation with plasmin.
    Nagaki K; Hashimoto C; Inai S
    Int Arch Allergy Appl Immunol; 1976; 50(1):1-13. PubMed ID: 126969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An IgG primary sequence exposure theory for complement activation using synthetic peptides.
    Boackle RJ; Johnson BJ; Caughman GB
    Nature; 1979 Dec; 282(5740):742-3. PubMed ID: 117384
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the interaction between protein A and immunoglobulin G. I. Effect of protein A on the functional activity of IgG.
    Langone JJ; Boyle MD; Borsos T
    J Immunol; 1978 Jul; 121(1):327-32. PubMed ID: 353195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the exposure of aromatic chromophores at the surface of the Fc domains of immunoglobulin G and their ability to bind complement.
    Isenman DE; Ellerson JR; Painter RH; Dorrington KJ
    Biochemistry; 1977 Jan; 16(2):233-40. PubMed ID: 13808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.